慢性间歇性缺氧引起的心血管和功能障碍:从适应到不适应
Claire Arnaud1, Emma Billoir1, Antonio F de Melo Junior2
1Université Grenoble-Alpes INSERM U1300, Laboratoire HP2, Grenoble, France.
The Journal of physiology
|October 26, 2023
概括
慢性间歇性缺氧 (CIH),常见于阻塞性睡眠呼吸暂停 (OSA),驱动高血压和心脏病. 研究突出了分子途径和针对已确定的疾病的向治疗的需要.
科学领域:
- 心血管和脏医学 心血管和脏医学
- 睡眠医学 睡眠医学
- 分子病理学分子病理学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 很普遍,与心血管和脏疾病有关,主要是由于慢性间歇性缺氧 (CIH).
- CIH诱导的高血压涉及同情性过度活跃和持续的分子变化,但对于已确定的疾病的有效干预措施尚不清楚.
- CIH对血管和心脏组织产生负面影响,促进内皮功能障碍,动脉样硬化,心房动和心脏重塑.
研究的目的:
- 审查CIH诱导的高血压和心脏脏损伤背后的分子机制.
- 探索已确定的CIH相关高血压干预措施的有效性.
- 讨论针对间歇性缺氧而产生的心结局的异质性,以及对表型分层的需要.
主要方法:
- 对CIH诱导的高血压,血管功能障碍,心脏损伤和病中的分子机制的文献综述.
- 分析促炎,促氧化和信号通路 (例如,氧化,HIF-1α,TLR4/NF-κB/NLRP3炎症体).
- 检查新出现的治疗点,包括肠-轴和亚利碳化合物受体 (AhR) 阻塞.
主要成果:
- CIH通过交感过度活动和分子途径驱动高血压,导致内皮功能障碍,血管重塑和加速动脉样硬化.
- 心肌的影响包括心房动,心脏重塑和收缩功能障碍,由氧化应激,炎症和信号干扰驱动.
- 损伤涉及TLR4/NF-κB/NLRP3炎症酶激活和热,导致高血压和慢性病.
结论:
- 通过复杂的分子通路,CIH深深地影响心血管和系统,需要对治疗干预措施有更深入的理解.
- 针对肠-轴和AhR的新兴疗法显示出减轻CIH相关损伤的希望.
- 基于心脏结结果对OSA表型的分层对开发有效的个性化治疗策略至关重要.
相关概念视频
Acute Respiratory Failure-II
249
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
249
Chronic Kidney Disease I: Introduction
18
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
18
Chronic Kidney Disease II: Clinical Manifestations
12
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
12
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Physiological Control of Respiration
2.1K
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
2.1K
Hypertension II: Pathophysiology
14
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14


